Mental Health

 
FDA Accepts Supplemental New Drug Application for Uzedy for Bipolar I Disorder
February 27, 2025

The FDA accepted the sNDA for risperidone (Uzedy) extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults.

Elevated Suicide Risk Identified in People with Headache Disorders
February 10, 2025

Post-traumatic headaches and trigeminal autonomic cephalalgia significantly increased the risk for attempted and completed suicide, according to new study.